ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.421,99
-0,22%
Dow Jones
38.549,85
-0,25%
Euro vs US Dollar
1,06959
-0,39%
Bitcoin
65.891,62
-1,29%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. NeoGenomics Inc (NEO)

  7. NeoGenomics Inc (NEO) News

NEO

NeoGenomics (NEO)

NeoGenomics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NEO
DatumZeitQuelleÜberschriftSymbolFirma
13/06/202422h08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NEONeoGenomics Inc
13/06/202414h00Business WireFort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer MonthNASDAQ:NEONeoGenomics Inc
04/06/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/06/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/06/202422h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/06/202422h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/06/202422h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/06/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/06/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/06/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
28/05/202414h05Business WireNeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment ManagementNASDAQ:NEONeoGenomics Inc
24/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NEONeoGenomics Inc
17/05/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
15/05/202403h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
15/05/202403h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
15/05/202403h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
15/05/202403h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
15/05/202403h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
30/04/202413h30Business WireNeoGenomics Reports First Quarter 2024 ResultsNASDAQ:NEONeoGenomics Inc
18/04/202413h05Business WireNeoGenomics Announces Senior Leadership PromotionsNASDAQ:NEONeoGenomics Inc
09/04/202413h00Business WireNeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NEONeoGenomics Inc
27/03/202413h30Business WireNeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual MeetingNASDAQ:NEONeoGenomics Inc
20/03/202412h00Business WireNeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) ReportNASDAQ:NEONeoGenomics Inc
06/03/202422h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
04/03/202423h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NEONeoGenomics Inc
01/03/202413h05Business WireNeoGenomics to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:NEONeoGenomics Inc
27/02/202422h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
27/02/202422h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
27/02/202422h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
27/02/202422h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NEONeoGenomics Inc
 Showing the most relevant articles for your search:NASDAQ:NEO

Kürzlich von Ihnen besucht

AMEX
XLF
Financial Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
NVDA
NVIDIA
NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
NASDAQ
GOOGL
Alphabet
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
MBG
MercedesBenz
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
TG
TUI1
Tui
TG
D7G
Nel ASA
DBI
SDXP
SDAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten